Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT02605512Not ApplicableCompleted

BreAst Cancer and Cardiotoxicity Induced by RAdioTherapy: the BACCARAT Study

Role: lead

NCT06073509Unknown

Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT

Role: lead

NCT02544178Unknown

Study of Neurological Complication After Radiotherapy for High Grade Glioblastoma

Role: lead

NCT02079272Not ApplicableWithdrawn

REBECCA Study (RadiothErapy for BrEast Cancer and CArdiotoxicity)

Role: lead

NCT01061463Completed

Occupational Cataracts and Lens Opacities in Interventional Cardiology : the O'CLOC Study

Role: lead

All 5 trials loaded